Janssen-Cilag International NV Clinical Trial
Janssen-Cilag International NV
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
58
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
0
PubMed author-name match
Trials
Studies that name Janssen-Cilag International NV Clinical Trial as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:26 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT04940039 · A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare SettingsJanssen-Cilag International NV · completed · Schizophrenia · study director
- Ph1NCT04266756 · A Study of Selexipag in Healthy Male ParticipantActelion · completed · Healthy · study director
- Ph1NCT03947814 · A Study of Orally Administered Pimodivir in Adult Participants With Renal ImpairmentJanssen-Cilag International NV · terminated · Kidney Failure, Chronic · study director
- Ph3NCT03852160 · A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant DepressionJanssen-Cilag International NV · withdrawn · Depressive Disorder, Treatment-Resistant · study director
- Ph3NCT03818035 · A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type PsoriasisJanssen-Cilag International NV · completed · Psoriasis · study director
- Ph1NCT03816631 · A Study of Orally Administered Pimodivir in Adult Participants With Hepatic ImpairmentJanssen-Cilag International NV · completed · Hepatic Impairment · study director
- N/ANCT03809325 · A Survey to Collect Treatment Experience Feedback From Patients, Physicians, Nurses and Carers After Switching to Paliperidone Palmitate 3-monthlyJanssen-Cilag International NV · completed · Schizophrenia · study director
- Ph1NCT03768609 · A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy AdultsJanssen-Cilag International NV · completed · Healthy · study director
- N/ANCT03574532 · A Study to Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human Metapneumovirus and Influenza A Infected Hospitalized Participants (Adults and Children)Janssen-Cilag International NV · completed · Respiratory Tract Infections · study director
- Ph1NCT03547024 · A Study in Healthy Participants to Evaluate the Effects of Multiple Doses of JNJ-55308942 on Cytochrome P450 Substrate Activity and on the Pharmacokinetics of Levonorgestrel/Ethinyl EstradiolJanssen-Cilag International NV · completed · Healthy · study director
- Ph1NCT03437590 · A Positron Emission Tomography (PET) Study to Investigate P2X7 Receptor Occupancy by JNJ-55308942 Using [18F]-JNJ-64413739Janssen-Cilag International NV · completed · Healthy · study director
- Ph1NCT03249402 · A Study to Evaluate the Effect of Multiple Oral Doses of JNJ-42847922 on the Steady-state Pharmacokinetics of an Oral Contraceptive Containing Ethinyl Estradiol and Levonorgestrel in Healthy Female Adult ParticipantsJanssen-Cilag International NV · completed · Healthy · study director
- N/ANCT03218488 · A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque PsoriasisJanssen-Cilag International NV · active not recruiting · Psoriasis · study director
- Ph1NCT03151486 · A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-55308942 in Healthy Male and Female ParticipantsJanssen-Cilag International NV · completed · Healthy · study director
- Ph1NCT03105986 · A Phase 1 Study to Evaluate the Effect of the Organic Anion Transporter Inhibitor Probenecid on the Pharmacokinetics of JNJ-64041575 in Healthy AdultsJanssen-Cilag International NV · completed · Healthy · study director
- Ph1NCT03088644 · A Study to Investigate P2X7 Receptor Occupancy by JNJ-54175446 With the Newly Developed P2X7 Receptor Positron Emission Tomography (PET) Tracer 18F-JNJ-64413739Janssen-Cilag International NV · completed · Healthy · study director
- Ph1NCT03023852 · A Study to Assess the Relative Oral Bioavailability of a Single Dose of JNJ-63623872/Oseltamivir Fixed-dose Combination Tablet and Single Agent Concept Formulations of JNJ-63623872 Compared to Their Respective Reference Formulation in Healthy Adult ParticipantsJanssen-Cilag International NV · completed · Healthy · study director
- Ph1NCT02860806 · Safety, Tolerability, Pharmacokinetic and Absolute Bioavailability Study of JNJ-63623872 Administered as an Intravenous Infusion and a 600-Milligram (mg) Oral Dose in Healthy AdultsJanssen-Cilag International NV · completed · Healthy · study director
- Ph1NCT02852395 · A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274Janssen-Cilag International NV · completed · Healthy · study director
- Ph1NCT02812251 · Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-61393215 in Healthy ParticipantsJanssen-Cilag International NV · completed · Healthy · study director
- N/ANCT02737657 · An Observational Study to Evaluate Tolerability of Canagliflozin and Sulphonylurea in Type 2 Diabetes Patients During RamadanJanssen-Cilag International NV · completed · Diabetes Mellitus, Type 2 · study director
- Ph3NCT02699385 · A Study to Evaluate the Safety and Efficacy of Domperidone in Pediatric Participants With Nausea and Vomiting Due to Acute GastroenteritisJanssen-Cilag International NV · terminated · Gastroenteritis · study director
- Ph1NCT02578472 · Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy ParticipantsJanssen-Cilag International NV · completed · Healthy · study director
- Ph1NCT02476058 · A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive DisorderJanssen-Cilag International NV · completed · Major Depressive Disorder · study director
- Ph1NCT02475148 · A Study to Investigate Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of JNJ-54175446 in Healthy ParticipantsJanssen-Cilag International NV · completed · Healthy · study director
- Ph2NCT02278419 · An Efficacy and Safety Study of a 8 or 12-Week Treatment Regimen of Simeprevir in Combination With Sofosbuvir in Treatment-Naive and Experienced Participants With Chronic Genotype 4 Hepatitis C Virus InfectionJanssen-Cilag International NV · completed · Hepatitis C · study director
- Ph2NCT02268864 · A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected ParticipantsJanssen-Cilag International NV · completed · Hepatitis C, Chronic · study director
- Ph1NCT02230878 · A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42847922 in Healthy ParticipantsJanssen-Cilag International NV · completed · Healthy · study director
- N/ANCT01926912 · A Study of Usage of Paliperidone Palmitate in Patients With Schizophrenia in a Hospital SettingJanssen-Cilag International NV · completed · Schizophrenia · study director
- Ph1NCT01877889 · A Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy VolunteersJanssen-Cilag International NV · completed · Healthy · study director
- Ph3NCT01813890 · A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy Compared With PlaceboJanssen-Cilag International NV · completed · Hallux Valgus · study director
- Ph1NCT01732237 · A Study to Investigate the Pharmacokinetics of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male ParticipantsJanssen-Cilag International NV · completed · Healthy · study director
- Ph3NCT01709084 · A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line TreatmentJanssen-Cilag International NV · completed · Human Immunodeficiency Virus-type 1 Infection · study director
- Ph1NCT01665638 · Effects of Canagliflozin on C-peptide Clearance in Healthy VolunteersJanssen-Cilag International NV · completed · Healthy · study director
- Ph1NCT01650597 · A Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-42165279 in Healthy Male ParticipantsJanssen-Cilag International NV · completed · Healthy Volunteers, Pharmacokinetics · principal investigator
- N/ANCT01601379 · Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease.Janssen-Cilag International NV · completed · Gastroesophageal Reflux Disease, Gastro-oesophageal Reflux, Gastro-Esophageal Reflux · study director
- Ph3NCT01448707 · A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current TreatmentJanssen-Cilag International NV · completed · Human Immunodeficiency Virus (HIV) Infections, Acquired Immunodeficiency Syndrome (AIDS) Virus · study director
- Ph3NCT01381809 · An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic SyndromesJanssen-Cilag International NV · completed · Myelodysplastic Syndromes · study director
- Ph1NCT01288196 · A Safety, Tolerability, Pharmacokinetics, and Immunogenicity Study of CNTO 6785 in Healthy VolunteersJanssen-Cilag International NV · completed · Healthy · study director
- Ph2NCT01286077 · Velcade Consolidation Bone StudyJanssen-Cilag International NV · completed · Multiple Myeloma · study director
- Ph3NCT01281527 · Paliperidone Palmitate Flexible Dosing in SchizophreniaJanssen-Cilag International NV · completed · Schizophrenia · study director
- Ph3NCT01081769 · Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral AntipsychoticsJanssen-Cilag International NV · completed · Schizophrenia · study director
- Ph4NCT01059773 · A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to MethotrexateJanssen-Cilag International NV · completed · Psoriasis · study director
- N/ANCT01026285 · InORS - International Observational Registry on Schizophrenia With Injectable Risperidone and Oral AntipsychoticsJanssen-Cilag International NV · completed · Schizophrenia · study director
- Ph4NCT00996177 · A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or IntravenouslyJanssen-Cilag International NV · completed · Pain, Analgesia, Patient-Controlled, Pain, Postoperative · study director
- Ph3NCT00980798 · Placebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the KneeJanssen-Cilag International NV · completed · Pain, Osteoarthritis, Hip, Osteoarthritis, Knee · study director
- Ph1NCT00965042 · Effect of Ceftobiprole on Human Intestinal MicrofloraBasilea Pharmaceutica · completed · Antimicrobial Agent, Cephalosporins, Drug Resistance · study director
- Ph2NCT00908232 · Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VDJanssen-Cilag International NV · completed · Multiple Myeloma · study director
- Ph2NCT00903682 · A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected PatientsJanssen-Cilag International NV · completed · HIV Infection, HIV, Acquired Immunodeficiency Syndrome · study director
- Ph3NCT00714688 · A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity DisorderJanssen-Cilag International NV · completed · Attention Deficit/ Hyperactivity Disorder · study director
- Ph3NCT00645099 · A 6 Month Study to Compare the Metabolic Effects of Paliperidone ER and Olanzapine in Patients With SchizophreniaJanssen-Cilag International NV · completed · Schizophrenia · study director
- Ph3NCT00460512 · An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended Release (ER) in Participants With SchizophreniaJanssen-Cilag International NV · completed · Schizophrenia · study director
- Ph3NCT00458302 · Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/RitonavirJanssen-Cilag International NV · completed · HIV Infections, AIDS Virus, Human Immunodeficiency Virus · study director
- Ph2NCT00441168 · Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple MyelomaJanssen-Cilag International NV · terminated · Multiple Myeloma · study director
- N/ANCT00440635 · Expanded Access Protocol (EAP) to Provide Bortezomib to Patients With Multiple Myeloma Who Have Received at Least 2 Previous Lines of Therapy and Are Refractory to or Have Relapsed After Their Last Therapy for Multiple MyelomaJanssen-Cilag International NV · completed · Multiple Myeloma · study director
- Ph2NCT00431769 · An Efficacy and Safety Study of Bortezomib Re-treatment in Multiple MyelomaJanssen-Cilag International NV · completed · Multiple Myeloma · study director
- Ph3NCT00307684 · Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)Janssen-Cilag International NV · completed · Attention Deficit Disorder With Hyperactivity · study director
- Ph3NCT00216476 · A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderJanssen-Cilag International NV · completed · Schizophrenia, Psychotic Disorders · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.